Tag:
AKR-501
Latest Headlines
Latest Headlines
Eisai inks $255M deal to buy AkaRx
New Jersey-based AkaRx is getting bought out for $255 million by Japan's Eisai, which picked up the option to buy the developer when it scooped up MGI Pharma in a $3.9 billion buyout almost two years
MGI lands $255M buyout option in drug deal
MGI Pharma has shelled out $45 million as a down payment for a Phase II therapy for thrombocytopenia, an abnormal drop in blood cells involved in forming blood clots. MGI says the deal to
